Neurol. praxi. 2016;17(4):240-243 | DOI: 10.36290/neu.2016.050

The onset of pain in myotonic dystrophy

MUDr. Olesja Parmová, MUDr. Stanislav Voháňka, CSc., MBA
Neurologická klinika LF MU a FN, Brno

Myotonic dystrophy is the most common form of muscular dystrophy in adults. It is a multisystem disease characterized by slowly

progressive weakness of skeletal muscles, myotonia, and multisystem involvement. Pain is a common and major symptom of the

disease and its frequency is approximately 75 %. The pain is not same for all patients, it has a variable intensity, temporal pattern,

localization, and character. In the majority of cases the pain has moderate intensity, long-term course, and fluctuates over time.

The intensity or even presence of pain is usually not associated with the patient's age and severity of the disease. The most often

reported localization of the pain is lower back, thighs, calf, arms, shoulders, and neck. Patients complain about various types

of pain - pulling, stabbing, exhausting, and sore or just discomfort in muscles, such as tension, tightness, tenderness, burning,

tingling, or cramping. The most frequently used treatment is medication.

Keywords: myotonic dystrophy, pain, muscular pain, neuropathic pain

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Parmová O, Voháňka S. The onset of pain in myotonic dystrophy. Neurol. praxi. 2016;17(4):240-243. doi: 10.36290/neu.2016.050.
Download citation

References

  1. Abresch RT, Carter GT, Jensen MP, Kilmer DD. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care 2002; 19: 39-48. Go to original source... Go to PubMed...
  2. Arsenault ME, Prévost C, Lescault A, Laberge C, Puymirat J, Mathieu J. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. Neurology 2006; 66(8): 1248-1250. Go to original source... Go to PubMed...
  3. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Thomas Caskey C. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992; 255: 1256-1258. Go to original source... Go to PubMed...
  4. George A, Schneider-Gold C, Zier S, Reiners K, Sommer C. Muskuloskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol 2004; 61: 1938-1942. Go to original source... Go to PubMed...
  5. Graven-Nielsen T, Mense S. The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin J Pain 2001; 17: 2-10. Go to original source... Go to PubMed...
  6. Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP, Tawil R, Thornton CA, Moxley RT 3rd. Diagnostic odyssey of patients with myotonic dystrophy. J Neurol 2013; 260(10): 2497-2504. Go to original source... Go to PubMed...
  7. Jensen MP, Abresch RT, Carter GT, McDonald CM. Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil 2005; 86(6): 1155-1163. Go to original source... Go to PubMed...
  8. Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, McDonald CM. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil 2008; 89(2): 320-328. Go to original source... Go to PubMed...
  9. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001; 293(5531): 864-867. Go to original source... Go to PubMed...
  10. Mäntyselkä PT, Turunen JH, Ahonen RS, Kumpusalo EA. Chronic pain and poor self-rated health. JAMA 2003; 290(18): 2435-2442. Go to original source... Go to PubMed...
  11. Martin EA, Barresi R, Byrne BJ, Tsimerinov EI, Scott BL, Walker AE, Gurudevan SV, Anene F, Elashoff RM, Thomas GD, Victor RG. Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy. Sci Transl Med 2012; 4(162): 162-155. Go to original source... Go to PubMed...
  12. Mense S. Muscle pain: mechanisms and clinical significance. Dtsch Arztebl Int 2008; 105(12): 214-219. Go to original source... Go to PubMed...
  13. Meola G, Moxley RT, III. Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 2004; 251(10): 1173-1182. Go to original source... Go to PubMed...
  14. Nelson MD, Rader F, Tang X, Tavyev J, Nelson SF, Miceli MC, Elashoff RM, Sweeney HL, Victor RG. PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy. Neurology 2014; 82(23): 2085-2091. Go to original source... Go to PubMed...
  15. Papadimas GK, Kekou K, Papadopoulos C, Kararizou E, Kanavakis E, Manta P. Phenotypic variability and molecular genetics in proximal myotonic myopathy. Muscle Nerve 2015; 51(5): 686-691. Go to original source... Go to PubMed...
  16. Parmová O, Voháňka S, Strenková J. The character and frequency of muscular pain in myotonic dystrophy and their relationship to myotonia. Int J Neurol Neurother 2014; 1: 2. Go to original source...
  17. Schneider-Gold C, Beer M, Kostler H, Buchner S, Sandstede J, Hahn D, Toyka KV. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle Nerve 2004; 30: 636-644. Go to original source... Go to PubMed...
  18. Smith AE, McMullen K, Jensen MP, Carter GT, Molton IR. Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil 2014; 93(5): 387-395. Go to original source... Go to PubMed...
  19. Suokas KI, Haanpää M, Kautiainen H, Udd B, Hietaharju AJ. Pain in patients with myotonic dystrophy type 2: a postal survey in Finland. Muscle Nerve 2012; 45(1): 70-74. Go to original source... Go to PubMed...
  20. Thomas GD. Functional muscle ischemia in Duchenne and Becker muscular dystrophy. Front Physiol 2013; 4:381. Go to original source... Go to PubMed...
  21. Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Engelen BG. High disease impact of myotonic dystrophy type 2 on physical and mental functioning. J Neurol 2011; 258(10): 1820-1826. Go to original source... Go to PubMed...
  22. Udd B, Meola G, Krahe R, Thornton C, Ranum LP, Bassez G, Kress W, Schoser B, Moxley R. 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord 2006; 16(6): 403-413. Go to original source... Go to PubMed...
  23. Ursu SF, Alekov A, Mao NH, Jurkat-Rott K. ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro. Acta Myol 2012; 31(2): 144-153. Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.